Soefje also discusses the growing role of pharmacists, technology, and comparative efficacy data in improving adherence, ...

Highlights of the conference coverage from the 2025 European Society of Medical Oncology (ESMO) Congress included content on ...

At ASH 2025, sonrotoclax demonstrated encouraging response rates and a favorable safety profile as a single-agent BCL2 ...

Sonrotoclax demonstrated a total overall response rate of 52%, including a complete response rate of 16%. However, Wang ...

Managed care organizations must prioritize dextromethorphan-bupropion based on sustained efficacy, improved remission rates, ...

Intravenous (IV) and subcutaneous (SC) formulations each play important roles in modern oncology care, with distinct ...

The FDA approved oral semaglutide (Wegovy) for weight loss and reducing major adverse cardiovascular events. Novo Nordisk ...

ACO maturity correlates with improved patient safety, suggesting experience and risk-bearing contracts enhance hospital quality and safety outcomes. Food-as-medicine programs improve nutrition-related ...

Heart failure-related deaths in homes or hospices increased from 17.33% in 1999 to 41.15% in 2022, while those in medical facilities and nursing homes decreased. Racial disparities persist, with ...

Obstructive sleep apnea (OSA) may be associated with an increased risk of developing Parkinson disease, although early treatment with continuous positive airway pressure (CPAP) could help mitigate ...

Expanding bispecific antibody access for multiple myeloma involves collaboration between academic centers and community ...

Explore the latest advancements in HER2-positive breast cancer treatments, highlighting the promising results of DESTINY-Breast trials for improved patient outcomes.